Selank: A Complete Guide to the Synthetic Tuftsin Analog Neuropeptide

Selank is a synthetic neuropeptide developed in Russia from the immune peptide tuftsin. It has been studied for stress resilience, cognitive function, and immune modulation, with a delivery profile that does not produce sedation. Selank is currently classified as Category 2 by the FDA and is not available for compounding in the United States.

What Is Selank?

Selank started as tuftsin - a four-amino-acid immune peptide your body makes naturally. Russian researchers added three more amino acids to make it more stable and longer-lasting.

The sequence: Thr-Lys-Pro-Arg-Pro-Gly-Pro. First four = tuftsin. Last three = stabilizing extension.

The modification worked. Selank resists enzymatic breakdown way better than natural tuftsin, which means it sticks around longer and does more work.

But here's what made Selank unique: it kept the immune benefits and added anxiety reduction plus cognitive enhancement. A three-for-one deal.

Delivery method? Nasal spray. No needles. Easier compliance. And the intranasal route might allow more direct access to the brain through olfactory pathways.

How Does Selank Work?

Selank works through multiple pathways. Here's the breakdown:

Neurotransmitter balancing: Selank tweaks GABA, serotonin, and dopamine - the big three for mood and cognition. More GABA means less neural excitability (relaxation). Better serotonin and dopamine means improved mood and focus.

BDNF boost: Like Semax, Selank appears to increase BDNF - the growth factor that keeps neurons healthy and plastic. Higher BDNF = better learning, memory, and stress resilience.

Immune system tuning: As a tuftsin derivative, Selank keeps its immune-modulating roots. It influences phagocytic activity and cytokine balance. Both brain and immune system in one package.

Gene expression changes: Selank appears to alter how genes involved in stress response and neurotransmitter metabolism get expressed. These changes might explain its longer-term effects on brain adaptation.

What makes Selank interesting for anxiety? No sedation. No cognitive fog. No dependence or withdrawal in animal studies.

Basically the opposite of benzodiazepines.

What Is Selank Studied For?

Research areas for Selank:

• Stress resilience and adaptation: Multiple studies have examined Selank's potential to support the body's adaptive response to various stressors, both psychological and physiological. Research has investigated its effects on stress-induced changes in behavior, hormone levels, and neural activity.
• Generalized anxiety: Clinical trials in Russia have studied Selank for generalized anxiety disorder and adjustment disorders with anxious mood. These investigations examined subjective anxiety ratings, physiological markers of stress, and quality of life measures.
• Cognitive function and focus: Research has explored Selank's potential nootropic properties, including effects on attention, memory consolidation, learning capacity, and mental clarity. Some studies have examined its use in conditions characterized by cognitive impairment.
• Immune system modulation: As a tuftsin derivative, Selank has been studied for its potential to support balanced immune function, particularly in the context of stress-induced immunosuppression. Research has examined its effects on various immune cell populations and cytokine profiles.
• Neurasthenia and asthenic conditions: Clinical studies in Russia have investigated Selank for conditions characterized by mental and physical fatigue, weakness, and reduced performance capacity.
• Mood and emotional regulation: Some research has explored Selank's potential effects on mood states, emotional processing, and the subjective experience of well-being.

The majority of Selank research has been conducted in Russia, where it is an approved pharmaceutical. Expanded English-language and Western replication studies would help broaden the international evidence base.

Regulatory Status and Availability

Selank's regulatory status depends on your geography:

United States: Category 2. Not approved for compounding. Not legally prescribable. Not available through legitimate medical channels.

Russia: Fully approved pharmaceutical. Prescribed by doctors since the mid-2000s for anxiety and cognitive issues. Available at regular pharmacies.

Rest of the world: Mostly not approved. The European Medicines Agency hasn't cleared it. Some countries might allow research use.

Future prospects: The FDA reviews Category 2 substances periodically as new data is submitted. PeptidePrescript monitors FDA guidance and will notify waitlist subscribers if Selank's status changes.

Side Effects and Safety Considerations

Safety profile based on Russian research:

Nasal spray side effects: Mild irritation, sneezing, nasal discharge in some users. Usually temporary and minor.

Systemic effects: Generally well-tolerated. Occasional reports of drowsiness, headache, or appetite changes - but these were uncommon in trials.

No sedation: This is huge. Unlike benzodiazepines, Selank doesn't knock you out or fog your brain. You can stay alert and functional.

No dependence: Animal studies show no physical dependence or withdrawal symptoms. That's a massive advantage over conventional anti-anxiety meds.

Drug interactions: Limited data, but theoretically Selank could interact with other medications affecting the same neurotransmitter systems. Medical supervision would be mandatory.

Special populations: Safety data in pregnancy, breastfeeding, pediatric populations, and people with significant medical conditions is limited, and these would be evaluated through medical consultation.

Most of the available safety data has been generated in Russian clinical contexts. Broader international research would help characterize response across diverse populations.

Frequently Asked Questions

How does Selank compare to Semax?

Selank and Semax are both synthetic neuropeptides developed in Russia, but they have different origins and studied effects. Semax is derived from adrenocorticotropic hormone (ACTH) and has been studied primarily for cognitive enhancement and neuroprotection. Selank, derived from tuftsin, has been studied more extensively for anxiolytic effects alongside cognitive benefits. Semax is believed to work primarily through melanocortin receptors, while Selank's mechanism involves neurotransmitter modulation and immune system effects. Both peptides have been studied in intranasal formulations, but they represent distinct pharmacological approaches to supporting brain function.

Is Selank legal in the United States?

Selank's legal status depends on the context of use. It is not approved by the FDA as a medication and cannot be marketed or sold for medical use. As a Category 2 peptide, it is not eligible for compounding by U.S. pharmacies. Possession for personal use exists in a regulatory gray area, but purchase, sale, or distribution for human consumption would likely violate FDA regulations. Research use may be permitted under appropriate institutional oversight and approvals. The legal landscape for research peptides is complex and subject to change.

How is Selank administered?

In clinical studies conducted in Russia, Selank has been administered primarily as an intranasal spray. Typical studied plans involve one to three applications per nostril, one to three times daily, though specific dosing varies by indication and study plan. The intranasal route allows for easier administration compared to injection and may facilitate more direct access to the central nervous system. Storage typically requires refrigeration to maintain peptide stability. However, because Selank is not currently available through legitimate medical channels in the U.S., these details are provided for educational context only.

Can I get Selank through PeptidePrescript?

No. Selank is currently classified as a Category 2 peptide and is not available for compounding in the United States. PeptidePrescript only offers peptides that hold Category 1 status and are eligible for legal compounding under FDA guidance. We continuously monitor regulatory updates, and if Selank's status changes to Category 1 in the future, we would evaluate it for inclusion in our offerings. Currently, we offer other well-researched peptides that are legally available under proper medical supervision.